|
Post by fofos2000i on May 25, 2016 7:51:10 GMT -5
|
|
|
Post by peppy on May 25, 2016 8:08:14 GMT -5
|
|
|
Post by fofos2000i on May 25, 2016 8:12:32 GMT -5
|
|
|
Post by victoria on May 25, 2016 8:42:03 GMT -5
Strictly the trial under Sanofi was 'suspended' per the clinicaltrials.gov site due to the Sanofi handover so perhaps this is the same trial but resuming? Either way good news if so. Odd the clinicaltrials.gov site has no update about it resuming though and no new entry for a new trial, as far as I can find so far. Perhaps an email to the trial contact will ascertain if trial is current but the posting date rather implies that it is? Maybe someone who has a young diabetic in their family could ask (I don't want to waste their time asking myslelf, doesnt seem fair to the clinicians if Im not capable of being involved even indirectly)
|
|
|
Post by peppy on May 25, 2016 8:42:22 GMT -5
|
|
|
Post by victoria on May 25, 2016 8:48:15 GMT -5
And it is quite a quick trial too so results wont be too delayed. Real progress. The juvenile diabetes market is really important for MNKD IMHO.
|
|
|
Post by mnholdem on May 25, 2016 9:01:04 GMT -5
The pediatric trial is two parts. The first goes quickly, the second part adds another year... unless the FDA changed the requirements.
|
|
|
Post by victoria on May 25, 2016 9:13:25 GMT -5
What is odd is that only recently MNKD tweeted:
MannKind Corporation @mannkindcorp May 9
$MNKD evaluating including amendments to #Afrezza Pediatric Study to support approval criteria in certain international markets.
MannKind Corporation @mannkindcorp May 9
$MNKD #Afrezza Pediatric Study Protocol expected to be complete 3Q16.
- perhaps they completed protocol amended sooner. Would be helpful if MNKD could include current clinical trial info on the website and update us on this since its unclear what the position is. (Dr Castagna if you're reading...)
|
|